MedTrace Logo

Novel Approach With Double Agent Artificial Oocyte Activation for Repeated Fertilization Failure Due to Combined Sperm and Oocyte Factor

NCT02418416 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2018-09-27

No results posted yet for this study

Summary

Novel approach for Oocyte fertilization failure for difficult cases not respond to traditional methods of assisted reproduction as intracytoplasmic sperm injection.

Conditions

Interventions

OTHER

Oocyte double chemical activation

Oocyte double chemical activation

Sponsors & Collaborators

  • Al Baraka Fertility Hospital

    collaborator OTHER

  • Banon IVF Center Assiut, Egypt

    collaborator OTHER

  • Ibn Sina Hospital

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
44 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-05-06
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • Bahrain
  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02418416 on ClinicalTrials.gov